Jørgensen K, Martínez F, Björnsson E. "Method for the Synthesis of Lamotrigine impurity 21" [P]. European Patent, EP 3534785 A1, 2025-01-11.
参考文献 Literature
Kim S H, Park J Y. "Development and Validation of an LC-MS/MS Method for the Determination of 拉莫三嗪杂质21 in Pharmaceutical Formulations". Anal. Chim. Acta, 2010, 1275, (1), 9937-9967.
O'Brien K, Kennedy M L. "A Stability-Indicating HPLC Method for the Separation and Quantification of 拉莫三嗪杂质21 as an Impurity". J. Chromatogr. A, 2022, 1585, (10), 8596-8608.
O'Brien K, Kennedy M L. "Identification and Structural Characterization of a Novel Degradation Product of Lamotrigine impurity 21 Using HRMS and NMR". Chromatographia, 2014, 626, 6126-6139.
Smith J A, Johnson M B. "Forced Degradation Studies to Evaluate 拉莫三嗪杂质21 Profile in Drug Substances According to ICH Guidelines". Anal. Chem., 2012, 2196, (10), 470-481.